Body image has become a key concern for women and men of all ages with research suggesting that once established in early life, body dissatisfaction can continue into adulthood.
The rise in prominence of reality TV shows and the increased usage of social media have helped stoke the debate around the issue, with media interest also ramping up around several controversial advertising campaigns.
The GEO has recently commissioned research aiming to better understand the role Government can play in easing the concerns of those who feel unhappy with how they look.
Alongside this research, the GEO wants to hear from key influencers, who remain on the front line of the body image debate, to better understand their experiences and thoughts on the issue. The Minister for Women and Equalities, Penny Mordaunt, will also be in attendance for part of the discussion.
Those attending the event include:
Further Information:
Further to the announcement that stocks of authorised flunixin injections for non-food horses are now available on the UK market (Meflosyl 5% Solution for Injection, Vm 42058/4085), the VMD is aware of vets’ concerns that demand may still exceed supply.
Whilst purchase of an authorised medicinal product should be the vets’ first choice, the VMD has a number of options to address availability issues, should they arise.
Stocks of flunixin solution for injection that were made available last year accompanied by a “Caution in Use” letter remain at wholesalers and the VMD will permit release of these in the event UK authorised product becomes unavailable (with a “Caution in Use” letter as previously permitted).
Vets may also consider applying to import an alternative product via the Special Import Scheme if a supply issue is identified. Vets are reminded that use of the Cascade must be based on clinical need. Where authorised products are temporarily unavailable vets should consider the likely quantities needed and purchase appropriately.
The VMD is working with wholesalers to monitor availability.
As before, any existing product held at the veterinary level can continue to be used.